Ultragenyx Pharmaceutical Inc. ($RARE)
Filing Information
| Accession Number | 0001193125-26-089107 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
16,187
Total Value
$227,538.26
P&L
+inf% (+$125,685.78)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Mar 1, 2026 | Grant/Award | 6,143 | $0.00 | $0.00 | 95,078 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 2, 2026 | Sale | 5,290 | $22.80 | $120,612.00 | 89,788 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 2, 2026 | Sale | 3,119 | $22.54 | $70,302.26 | 86,669 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 3, 2026 | Sale | 1,635 | $22.40 | $36,624.00 | 85,034 | Direct | โ | View Details |